| Reconciliation of Federal Statutory Income Tax Provision To Company's Actual Provision | A reconciliation of the federal statutory income tax provision to our actual provision for the years ended December 31, 2020 and 2019 is as follows: 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  
|  |  |  | 2020 |  |  | 2019 |  |  
| Pre-tax book income (loss) |  | $ | (6,187,020) |  |  |  | $ | (4,779,179) |  |  |  
| Expected tax at 21%  |  | (1,299,274) |  |  |  | (1,008,353) |  |  |  
|  |  |  |  |  |  |  |  |  
| Permanent differences: |  |  |  |  |  |  |  
|  |  |  |  |  |  |  |  |  
|  | Mark to market |  | 20,665 |  |  |  | 4,133 |  |  |  
|  | Goodwill impairment |  | 613,677 |  |  |  | 775,572 |  |  |  
|  | Intangible Amortization |  | (84,085) |  |  |  | (105,573) |  |  |  
|  |  |  |  |  |  |  |  |  
|  |  |  |  |  |  |  |  |  
|  | Other |  | 2,757 |  |  |  | 684 |  |  |  
|  |  |  |  |  |  |  |  |  
| State taxes: |  |  |  |  |  |  |  
|  | Current |  | 30,171 |  |  |  | 15,194 |  |  |  
|  | Deferred |  | (161,203) |  |  |  | (110,517) |  |  |  
|  |  |  |  |  |  |  |  |  
| Other items: |  |  |  |  |  |  |  
|  | Federal research and development credits |  | (13,161) |  |  |  | (48,153) |  |  |  
|  | Change in valuation allowance |  | 1,049,000 |  |  |  | 1,479,000 |  |  |  
|  | Deferred tax past year true-up's |  | 11,767 |  |  |  | (30,981) |  |  |  
|  |  |  |  |  |  |  |  |  
|  |  |  |  |  |  |  |  |  
|  |  |  |  |  |  |  |  |  
|  |  |  |  |  |  |  |  |  
|  |  |  |  |  |  |  |  |  
|  | Other |  | (140,143) |  |  |  | (955,812) |  |  |  
| Income tax provision |  | $ | 30,171 |  |  |  | $ | 15,194 |  |  |  | 
| Schedule of Deferred Tax Assets | The components of net deferred tax assets recognized in the accompanying consolidated balance sheets at December 31, 2020 and 2019 are as follows: 
|  |  |  |  |  |  |  |  |  |  |  |  |  
|  | 2020 |  | 2019 |  
| Net operating loss carryforwards | $ | 9,341,000 |  |  | $ | 8,299,000 |  |  
| R&D and ITC credit carryforwards | 313,000 |  |  | 317,000 |  |  
| Accrued expenses and other | 267,000 |  |  | 1,224,000 |  |  
| Intangibles | 191,000 |  |  | — |  |  
| Leases | 25,000 |  |  | — |  |  
| Accounts receivable | 108,000 |  |  | 20,000 |  |  
| Stock options | 238,000 |  |  | — |  |  
| Inventory | 217,000 |  |  | 78,000 |  |  
| Property, plant and equipment | 790,000 |  |  | 779,000 |  |  
| Other | 276,000 |  |  | — |  |  
| Deferred tax assets | 11,766,000 |  |  | 10,717,000 |  |  
| Valuation allowance | (11,766,000) |  |  | (10,717,000) |  |  
| Deferred tax assets, net | $ | — |  |  | $ | — |  |  |